Actor portrayal.
New targets continue to emerge that have
the potential to advance the investigation
into higher-risk MDS.
Could research into a new class of immunotherapy advance our understanding of HR-MDS?
Explore Research Into Higher-Risk MDSHR-MDS, higher-risk myelodysplastic syndrome; MDS, myelodysplastic syndrome.
Reference: 1. Chao MP, Takimoto CH, Feng DD, et al. Front Oncol. 2020;9:1380. doi:10.3389/fonc.2019.01380